HCW Biologics Inc is trading at $1.83 (11.6% down) following its recent first-quarter 2026 update and shifts in its capital structure.
- The company is under pressure to regain compliance with Nasdaq’s $1 minimum bid-price rule.
- Investors are monitoring an upcoming shareholder meeting on June 15, 2026, which is contributing to stock volatility despite a slightly higher broader market.